US pharma major AbbVie recently announced top-line results from one of two parallel studies of the pivotal Phase III UP-AA ...

The cancer immunotherapy market is bracing for its next growth phase as bispecific T-cell engagers gain momentum, according ...

German family-owned pharma major Boehringer Ingelheim and New York-based Click Therapeutics today announced that the pivotal ...

UK pharma major GSK (LSE: GSK) today announced that, in connection with the mRNA patent settlement reached between CureVac ...

French vaccines developer Valneva announced that the US Food and Drug Administration (FDA) has removed its recommended pause ...

A Californian company developing new treatments to help organ transplant patients keep their transplanted organs healthy over the long term.

US clinical-stage biotech Keros Therapeutics has announced a strategic realignment designed to reallocate resources towards ...

Danish biotech Genmab (Nasdaq: GMAB) posted second-quarter revenue of $925 million, up 19% from a year earlier, driven by ...

Drug-resistant infections now claim more lives each year than HIV/AIDS or malaria, and the toll is rising. The World Health Organization warns that without urgent action, antimicrobial resistance (AMR ...

Danish biotech Genmab (Nasdaq: GMAB) and US partner AbbVie (NYSE: ABBV) have reported a decisive win in a Phase III study of ...

The National Institute for Health and Care Excellence (NICE) has issued final guidance recommending Chiesi’s idebenone within ...

China-based Everest Medicines (HKEX: 1952) has secured full regulatory approval for Nefecon (budesonide) in Taiwan, marking the last of its Asian territories to grant the go-ahead for the ...